Immunohistochemical staining of moesin in prostatic adenocarcinoma show significantly reduced staining intensity in Stage 4 compared to Stage 2 PCa [77], and further studies on the protein may help elucidate its role in prostate cancer progression. This evidence concerns the gene MSN and prostate adenocarcinoma.